TRJNF (Trajan Group Holdings) Notes Receivable: $0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TRJNF Trajan Group Holdings Ltd TRJNF
38 GF Score
Price $0.40
GF Value $1.53
! 2 Warning Signs
View Full Analysis

What is Trajan Group Holdings Notes Receivable?

Trajan Group Holdings TRJNF 38 Notes Receivable is $0.0 Mil as of Dec. 2025. GuruFocus rates TRJNF with a GF Score™ of 38/100 and a GF Value™ of $1.53. The stock has 2 warning signs investors should review.

Trajan Group Holdings's Notes Receivable for the quarter that ended in Dec. 2025 was $0.0 Mil.

Trajan Group Holdings Notes Receivable Related Terms

Trajan Group Holdings Notes Receivable Historical Data

* Premium members only.

The historical data trend for Trajan Group Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trajan Group Holdings Notes Receivable Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TRJNF
38GF Score
Trajan Group Holdings Ltd TRJNF
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trajan Group Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.0 Mil mean?
Trajan Group Holdings (TRJNF) has a Notes Receivable of $0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Trajan Group Holdings and its competitors.
Is Trajan Group Holdings' Notes Receivable too high?
Trajan Group Holdings' current Notes Receivable is $0.0 Mil. Overall, Trajan Group Holdings has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' Notes Receivable compare to ISRG and BDX?
Trajan Group Holdings' Notes Receivable of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Trajan Group Holdings and its competitors. Trajan Group Holdings's current Notes Receivable is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Trajan Group Holdings (TRJNF) has a current Notes Receivable of $0.0 Mil. The stock's GF Value™ is $1.53, compared to a current price of $0.40 — trading 73.9% below its estimated fair value. The current Notes Receivable is $0.0 Mil. Trajan Group Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Trajan Group Holdings (TRJNF), the current Notes Receivable is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trajan Group Holdings (TRJNF) Overvalued in 2026?

Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued. The current stock price of $0.40 is trading 73.9% below its estimated GF Value™ of $1.53.

Key valuation signals for TRJNF:

  • Notes Receivable: $0.0 Mil
  • GF Value™: $1.53 vs. price of $0.40 (73.9% below fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the TRJNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trajan Group Holdings Business Description

Other Exchanges TRJ:Australia
Address 7 Argent Place, Ringwood, VIC, AUS, 3134
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
38GF Score

Get the complete analysis for TRJNF

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$1.53
GF Value